New York State Common Retirement Fund Karuna Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$75.8 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$161.01 - $317.85 $755,780 - $1.49 Million	-4,694 Reduced 4.8%	93,089 $29.5 Million
Q3 2023 Nov 07, 2023	SELL	$164.66 - $218.08 $1.12 Million - $1.48 Million	-6,797 Reduced 6.5%	97,783 $16.5 Million
Q2 2023 Aug 07, 2023	BUY	$176.32 - $240.22 $3.47 Million - $4.73 Million	19,674 Added 23.17%	104,580 $22.7 Million
Q1 2023 May 02, 2023	BUY	$161.33 - $204.36 $2.42 Million - $3.07 Million	15,000 Added 21.46%	84,906 $15.4 Million
Q4 2022 Jan 30, 2023	BUY	$191.53 - $236.82 $2.5 Million - $3.09 Million	13,053 Added 22.96%	69,906 $13.7 Million

Q3 2022 Nov 08, 2022	BUY	$123.79 - $277.42 $4.42 Million - $9.9 Million	35,670 Added 168.39%	56,853 $12.8 Million
Q2 2022 Aug 04, 2022	BUY	$93.97 - $143.33 $345,339 - $526,737	3,675 Added 20.99%	21,183 $2.68 Million
Q1 2022 May 05, 2022	BUY	$98.9 - $132.37 $140,536 - $188,097	1,421 Added 8.83%	17,508 $2.22 Million
Q4 2021 Feb 02, 2022	SELL	$110.64 - $159.4 $4,868 - $7,013	-44 Reduced 0.27%	16,087 $2.11 Million
Q3 2021 Nov 02, 2021	SELL	$101.2 - $125.87 $313,821 - $390,322	-3,101 Reduced 16.12%	16,131 $1.97 Million
Q2 2021 Aug 02, 2021	BUY	$107.45 - $135.95 $562,178 - $711,290	5,232 Added 37.37%	19,232 $2.19 Million
Q1 2021 May 11, 2021	SELL	$95.46 - $133.08 $105,006 - $146,388	-1,100 Reduced 7.28%	14,000 $1.68 Million
Q3 2020 Nov 05, 2020	BUY	$71.31 - $109.74 $64,179 - $98,766	900 Added 6.34%	15,100 $1.17 Million
Q2 2020 Aug 07, 2020	BUY	$62.14 - $117.21 $621,400 - $1.17 Million	10,000 Added 238.1%	14,200 $1.58 Million
Q4 2019 Feb 05, 2020	BUY	$11.44 - $123.99 $48,048 - $520,758	4,200 New	4,200 $316,000

Others Institutions Holding KRTX

# of Institutions

Shares Held

333K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account